Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
TINA.org Finds U-Haul Using Bait-and-Switch Pricing Scheme
MADISON, CONN. May 6, 2025 – U-Haul is engaged in a bait-and-switch pricing scheme with its $19.95 truck rental ads, according to an investigation by consumer advocacy organization truthinadvertising.org (TINA.org).…
U-Haul Needs to Pack Up Its Deceptive ‘$19.95’ Truck Ads
TINA.org calls on regulators to stop moving company’s bait and switch.
FTC, Nevada Sue IM Mastery Academy
Complaint alleges IML was a $1.2 billion scam.
OmegaXL: Backed by Research
What you should know about ingredient studies.
Make Money with Fran/Passive Digital Mastery
Will master resell rights actually give you the dream life?